Chapter References

1. Martin, W.R., Jasinski, D.R., Haertzen, C.A., et al. (1973). Methadone—a re-evaluation. Archives of General Psychiatry, 28, 286-95.

2. Dollery, C. (ed.) (1991). Therapeutic drugs, Vols 1 and 2. Churchill Livingstone, Edinburgh.

3. Ward, J., Mattick, R.P., and Hall, W. (ed.) (1998). Methadone maintenance treatment and other opioid replacement therapies. Harwood Academic, Australia.

4. Blaine, J.D., Thomas, D.B., Barnett, G., Whysner, J.A., and Renault, P.F. (1981). Levo-alpha acetylmethadol (LAAM) clinical utility and pharmaceutical development. In Substance abuse: clinical problems and perspectives (ed. J.H. Lowinson and P. Ruiz), pp. 360-88. Williams and Wilkins, Baltimore, MD.

5. Jasinski, D.R., Pevnick, J.S., and Griffiths, J.D. (1978). Human pharmacology and abuse potential of the analgesic buprenorphine. Archives of General Psychiatry, 35, 501-16.

6. Cowan, A. and Lewis, J.W. (ed.) (1995). Buprenorphine: combatting drug abuse with a unique opioid Wiley-Liss, New York.

7. Bickel, W.K. and Amass, L. (1995). Buprenorphine treatment of opioid dependence: a review. Experimental and Clinical Psychopharmacology, 3, 477-89.

8. Nutt, D.J. (1997). Receptor pharmacology of buprenorphine. Research and Clinical Forums, 19, 9-15.

9. Weiss, B. (1959). Dihydrocodeine: a pharmacologic review. American Journal of Pharmacy and the Sciences Supporting Public Health, 131, 286-301.

10. Kleber, H.D. and Kosten, T.R. (1984). Naltrexone induction: psychologic and pharmacologic strategies. Journal of Clinical Psychiatry, 45, 29-38.

11. Gonzalez, J.P. and Brogden, R.N. (1988). Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence. Drugs, 35, 192-213.

12. Mello, N.K., Mendelson, J.H., Kuehnle, J.C., and Sellars, M.S. (1980). Operant analysis of human heroin self-administration and the effects of naltrexone. Journal of Pharmacology and Experimental Therapeutics, 216, 45-54.

13. Handal, K.A., Schauben, J.L., and Salamone F.R. (1983). Naloxone. Annals of Emergency Medicine, 12, 438-45.

14. McNicholas, L.F. and Martin, W.R. (1984). New and experimental therapeutic roles for naloxone and related opioid antagonists. Drugs, 27, 81-93.

15. Gossop, M. (1988). Clonidine and the treatment of the opiate withdrawal syndrome. Drug and Alcohol Dependence, 21, 253-9.

16. Gold, M.S. (1993). Opiate addiction and the locus ceruleus: the clinical utility of clonidine, naltrexone, methadone and buprenorphine. Psychiatric Clinics of North America, 16, 61-73.

17. Myles, J.S. (1996). Alpha-2-adrenoceptors in addiction. Journal of Psychopharmacology, 10 (Supplement 3), 49-52.

18. Kahn, A., Mumford, J.P., Rogers, G.A., and Beckford, H. (1997). Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital. Drug and Alcohol Dependence, 44, 57-61.

19. Herman, B.H. and O'Brien, C.P. (1997). Clinical medications development for opiate addiction: focus on non-opioids and opioid antagonists for the amelioration of opiate withdrawal symptoms and relapse prevention. Seminars in Neuroscience, 9, 158-72.

20. Littleton, J. (1995). Acamprosate in alcohol dependence: how does it work? Addiction, 90, 1179-88.

21. Wilde, M.I. and Wagstaff, A.J. (1997). Acamprosate: a review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Drugs, 53, 1038-53.

22. Banys, P. (1988). The clinical use of disulfiram (Antabuse): a review. Journal of Psychoactive Drugs, 20, 243-60.

23. Heather, N. (1993). Disulfiram treatment for alcohol problems: is it effective and, if so, why? In Treatment options in addiction: medical management of alcohol and opiate abuse (ed. C. Brewer), pp. 1-18. Gaskell, London.

24. Brewer, C. (1984). How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. British Journal of Psychiatry, 144, 200-2.

25. Majumdar, S.K. (1990). Chlormethiazole: current status in the treatment of the acute ethanol withdrawal syndrome. Drug and Alcohol Dependence, 27, 201-7.

Positive Thinking Power Play

Positive Thinking Power Play

Learning About A Positive Thinking Power Play Can Have Amazing Benefits For Your Life And Success. Learn About Positive Thinking Power Play -And Have A Look At 10 Steps to Success To Create Amazing Results.

Get My Free Ebook

Post a comment